# Post-Authorization Long-Term Safety Study of LUTATHERA

> **NCT03691064** · — · ACTIVE_NOT_RECRUITING · sponsor: **Advanced Accelerator Applications** · enrollment: 1014 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** LUTATHERA

## Key facts

- **NCT ID:** NCT03691064
- **Lead sponsor:** Advanced Accelerator Applications
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-28
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 1014 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03691064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03691064, "Post-Authorization Long-Term Safety Study of LUTATHERA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03691064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*